Here are relevant reports on : lung-cancer-treatment-market
-
Fiber Food Ingredients Market, By Type Soluble Fiber, Insoluble Fiber, Resistant Fibres, Others) By Function (Cancer
- Published: December 2026
- Price: $ 4950
- TOC Available:
-
Contract Research Organization (CRO) Services Market by Type (Early Phase, Clinical, Lab, Consulting), Therapeutic Area [Oncology (Breast, Lung), Infectious, Neurology, Vaccines], Modality, Model (FSO, FSP), End User, Competition - Global Forecast to 2031
The global contract research organization services market is projected to reach USD 140.32 billion by 2031, growing at a CAGR of 8.6% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: April 2026
- Price: $ 7150
- TOC Available:
-
Perfusion Systems Market (Cardiopulmonary Perfusion, by Component (Heart-lung Machines, Oxygenators), Ex Vivo Organ Perfusion, Technique (Hypothermic, Normothermic), Cell Perfusion, by Type (Bioreactor, Microfluidic)) - Global Forecast to 2021
The global perfusion systems market is expected to reach USD 1,198.8 Million by 2021 from USD 989.4 Million in 2016, at a CAGR of 3.9%. The growth of the market can be attributed to the increasing prevalence of cardiovascular & respiratory diseases, initiatives by governments & NGOs to encourage organ donation, increasing investment in cell-based research, and developments in biologics manufacturing. The high cost of organ transplantation and organ supply-demand gap, however, are expected to hinder the growth of the market.
- Published: April 2017
- Price: $ 4950
- TOC Available:
-
Cardiac Perfusion Market by Product (Oxygenation Systems, Reservoirs, Heart-Lung Machines, Arterial Filters, Heat Transfer Systems, Blood Monitoring Systems, Auto transfusion Systems) - Forecast to 2020
Cardiac perfusion systems are used to temporarily replace the functions of the heart during cardiac surgeries. The cardiac perfusion system market is broadly segmented into oxygenation systems, reservoirs, heart-lung machines, myocardial protection systems, arterial filters, blood monitoring systems, autotransfusion systems, hemoconcentrators, heat transfer systems, tubings and cannulae, and others. The pivotal factor driving the growth of this market is increasing number of cardiac surgeries. Increasing prevalence of cardiac and lung diseases in developed as well as developing further propels the growth of this market. However, insufficient number of well-trained surgeons in developing nations, unstable reimbursement policies, and competition from local players with low cost products are inhibits the growth of this market. North America is the largest market for cardiac perfusion system market, with the U.S. contributing a major share, followed by Europe, Asia-Pacific, and the Rest of the World. North America and Europe will continue to dominate the market during the forecast period owing to the growing number of cardiac and lung surgeries and technological advancement in cardiac perfusion system. However, a majority of the growth in the cardiac perfusion system market is expected to be from emerging markets in the Asia-Pacific, owing to the growing number of cardiovascular patients, increasing awareness towards healthcare, and technological advancement in cardiovascular surgery in these regions.
- Published: December 2026
- Price: $ 4950
- TOC Available:
-
Global Colorectal Cancer Market (2010-2015)
2008 saw almost 12 million patients diagnosed with cancer. Despite, increasing technological advancements and research the deaths due to cancer were about 8 million people in 2008. Lung cancer accounts for the highest mortality rate.
- Published: December 2026
- Price: $ 4950
- TOC Available:
-
Global Breast Cancer Drugs Market
There are about one million new cases of breast cancer every year. Breast cancer accounts for about 10% of world wide cancer. There has been significant increase in awareness levels with respect to impact on survival rates incase of early diagnosis. Therefore, opening novel opportunities for breast cancer drugs market.
- Published: December 2026
- Price: $ 4950
- TOC Available:
-
Prostate Cancer Therapeutics Market (2010-2020) (Opportunity Analysis, Pipeline Assessment and Global Market Forecast)
Prostate cancer is the most frequently diagnosed cancer in men. In terms of loss of life from any disease, prostate cancer ranks eleventh; and it ranks sixth in terms of cancer-related mortality in men. The prostate cancer market has a huge demand for new and novel drugs that address unmet needs such as improved survival time, less toxicity, increased progression free survival, increased effectiveness, and lower cost.
- Published: November 2011
- Price: $ 4950
- TOC Available:
-
Airway Stent/Lung Stent Market by Type (Tracheal, Bronchial, Laryngeal Stent), Product (Non-Expandable, Self-Expandable Stents), Material (Metal (Nitinol, Stainless Steel), Silicone, Hybrid), End User (Hospitals, ASCs) - Global Forecasts to 2024
The lung stent market is projected to reach USD 120 million by 2024, at a CAGR of 6.7%. The major players operating in the lung stent market include Boston Scientific Corporation (US), Taewoong Medical Co., Ltd. (South Korea), Micro-Tech (Nanjing) Co., Ltd. (China), Novatech SA (France), Boston Medical Products, Inc. (US), E. Benson Hood Laboratories, Inc. (US), Merit Medical Systems, Inc. (US), Cook Group (US), EFER ENDOSCOPY (France), ENDO-FLEX GmbH (Germany), Standard Sci. Tech Inc. (South Korea), and Stening SRL (Argentina), among others.
- Published: June 2019
- Price: $ 4950
- TOC Available:
-
Primary Cells Market by Type (Hematopoietic, Dermatocytes, Hepatocytes, Gastrointestinal, Lung, Renal, Heart, Musculoskeletal), Origin (Human Primary Cells, Animal Primary Cells), End User (Pharma Biotech, CROs, Academia), Region - Global Forecast to 2028
The global primary cells market, valued at US$1.5 billion in 2022, stood at US$1.7 billion in 2023 and is projected to advance at a resilient CAGR of 10.5% from 2023 to 2028, culminating in a forecasted valuation of US$2.8 billion by the end of the period. The growth of this market can be attributed to factors such as the is the growing advantages of primary human cells over cell lines, rising growth in pharmaceutical & biotechnology industries, increasing demand for monoclonal antibodies, Government investments for cell-based research, and increasing cancer research.
- Published: July 2023
- Price: $ 4950
- TOC Available:
-
Robotic Radiotherapy Market Size by Product (System, Software, 3D Camera), Technology (LINAC, Stereotactic, Particle Therapy), Application (Lung, Breast, Colorectal), End-User (Hospitals, Radiotherapy Centres), & Region - Global Forecast to 2028
The global robotic radiotherapy market, valued at US$0.8 billion in 2021, stood at US$1.1 billion in 2023 and is projected to advance at a resilient CAGR of 11.9% from 2023 to 2028, culminating in a forecasted valuation of US$1.9 billion by the end of the period. The market's expansion is driven by several factors, including the global rise in cancer cases, advancements in automation technologies enhancing the precision of radiotherapy, a growing preference for non-invasive cancer treatments, and the rapid proliferation of cancer treatment facilities.
- Published: April 2024
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
